Merck and Moderna release promising data on cancer vaccine trial

0:00-3:33

A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system to go after cancer cells.

Publisher

All Things Considered

Published

October 23, 2026

Duration

4 min

Format

Podcast

Category

News · Daily News

Source

RSS feed

AT

All Things Considered

@allthingsconsidered

#merck #modernareleasepromising #cancervaccinetrial

The Nile